The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer
Abstract
PURPOSE: Radiotherapy for head and neck cancer causes acute and chronic xerostomia and acute mucositis. Amifositine and its active metabolite, WR-1065, accumulate with high concentrations in the salivary glands. This randomized trial evaluated whether amifostine could ameliorate these side effects without compromising the effectiveness of radiotherapy in these patients. PATIENTS AND METHODS: Patients with previously untreated head and neck squamous cell carcinoma were eligible. Primary end points included the incidence of grade ≥ 2 acute xerostomia, grade ≥ 3 acute mucositis, and grade ≥ 2 late xerostomia and were based on the worst toxicity reported. Amifostine was administered (200 mg/m 2 intravenous) daily 15 to 30 minutes before irradiation. Radiotherapy was given once daily (1.8 to 2.0 Gy) to doses of 50 to 70 Gy. Whole saliva production was quantitated preradiotherapy and regularly during follow-up. Patients evaluated their symptoms through a questionnaire during and after treatment. Local-regional control was the primary antitumor efficacy end point. RESULTS: Nausea, vomiting, hypotension, and allergic reactions were the most common side effects. Fifty-three percent of the patients receiving amifostine had at least one episode of nausea and/or vomiting, but it only occurred with 233 (5%) of 4,314 doses. Amifostine reduced grade ≥ 2 acute xerostomia from 78% to 51% (P < .0001) and chronic xerostomia grade ≥ 2 from 57% to 34% (P = .002). Median saliva production was greater with amifostine (0.26 g v 0.10 g, P = .04). Amifostine did not reduce mucositis. With and without amifostine, 2-year local-regional control, disease-free survival, and overall survival were 58% versus 63%, 53% versus 57%, and 71% versus 66%, respectively. CONCLUSION: Amifostine reduced acute and chronic xerostomia. Antitumor treatment efficacy was preserved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Brizel, D. M., Albers, M. E., Fisher, S. R., Scher, R. L., Richtsmeier, W. J., Hars, V., George, S. L., Huang, A. T., & Prosnitz, L. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382503 · Cited by 1,127
Self-citationMinimization: A new method of assigning patients to treatment and control groups
Taves, D. R. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974155443 · Cited by 891
Horiot, J. C., Le Fur, R., N'Guyen, T., Chenal, C., Schraub, S., Alfonsi, S., Gardani, G., Van Den Bogaert, W., Danczak, S., Bolla, M., et al. (1992) · Radiotherapy and Oncology · doi:10.1016/0167-8140(92)90242-m · Cited by 676
The randomization and stratification of patients to clinical trials
Zelen, M. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90015-0 · Cited by 613
Peters, L. J., Goepfert, H., Ang, K. K., Byers, R. M., Maor, M. H., Guillamondegui, O., Morrison, W. H., Weber, R. S., Garden, A. S., Frankenthaler, R. A., et al. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90167-t · Cited by 538
Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Panitch, H. S., Rose, J. W., Schiffer, R. B., et al. (1998) · Neurology · doi:10.1212/wnl.50.3.701 · Cited by 509
Horiot, J.-C., Bontemps, P., van den Bogaert, W., Le Fur, R., van den Weijngaert, D., Bolla, M., Bernier, J., Lusinchi, A., Stuschke, M., Lopez-Torrecilla, J., et al. (1997) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00079-0 · Cited by 506
Oral Pilocarpine for Post-Irradiation Xerostomia in Patients with Head and Neck Cancer
Johnson, J. T., Ferretti, G. A., Nethery, W. J., Valdez, I. H., Fox, P. C., Ng, D., Muscoplat, C. C., & Gallagher, S. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308053290603 · Cited by 484
Kemp, G., Rose, P., Lurain, J., Berman, M., Manetta, A., Roullet, B., Homesley, H., Belpomme, D., & Glick, J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2101 · Cited by 463
LeVeque, F. G., Montgomery, M., Potter, D., Zimmer, M. B., Rieke, J. W., Steiger, B. W., Gallagher, S. C., & Muscoplat, C. C. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1124 · Cited by 290
The role of WR-2721 in radiotherapy and/or chemotherapy.
Yuhas, J. M., Spellman, J. M., & Čulo, F. (1980) · PubMed · Cited by 281
Merlano, M., Benasso, M., Corvo, R., Rosso, R., Vitale, V., Blengio, F., Numico, G., Margarino, G., Bonelli, L., & Santi, L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.9.583 · Cited by 249
Valdez, I. H., Atkinson, J. C., Ship, J. A., & Fox, P. C. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90143-j · Cited by 228
Improved methodology for analyzing local and distant recurrence.
Gelman, R., Gelber, R., Henderson, I. C., Coleman, C. N., & Harris, J. R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.3.548 · Cited by 224
p Value Adjustments for Multiple Tests in Multivariate Binomial Models
Westfall, P. H., & Young, S. S. (1989) · Journal of the American Statistical Association · doi:10.1080/01621459.1989.10478837 · Cited by 187
Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer
Büntzel, J., Küttner, K., Fröhlich, D., & Glatzel, M. (1998) · Annals of Oncology · doi:10.1023/a:1008282412670 · Cited by 181
McDonald, S. A., Meyerowitz, C., Smudzin, T., et al. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90562-2 · Cited by 113
Distribution of 35 S-Labeled WR-2721 in Normal and Malignant Tissues of the Mouse
Utley, J. F., Marlowe, C., & Waddell, W. J. (1976) · Radiation Research · doi:10.2307/3574479 · Cited by 103
Analysis of the probability and risk of cause-specific failure
Caplan, R. J., Pajak, T. F., & Cox, J. D. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90416-2 · Cited by 99
Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer
Wasserman, T. H., Mackowiak, J. I., Brizel, D. M., Oster, W., Zhang, J., Peeples, P. J., & Sauer, R. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00735-5 · Cited by 72
Self-citationOral mucosal status and major salivary gland function
Wolff, Ä., Fox, P. C., Ship, J. A., Atkinson, J. C., Maeynski, A. A., & Baum, B. J. (1990) · Oral Surgery Oral Medicine Oral Pathology · doi:10.1016/0030-4220(90)90177-t · Cited by 63
Rasey, J. S., Grünbaum, Z., Krohn, K. A., Menard, T. W., & Spence, A. M. (1985) · Radiation Research · doi:10.2307/3576436 · Cited by 46
Cited by
Forastiere, A., Koch, W., Trotti, A., & Sidransky, D. (2001) · New England Journal of Medicine · doi:10.1056/nejmra001375 · Cited by 1,250
Bentzen, S. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1950 · Cited by 1,096
Effects of radiation on normal tissue: consequences and mechanisms
Stone, H. B., Coleman, C. N., Anscher, M. S., & McBride, W. H. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01191-4 · Cited by 931
Rubenstein, E. B., Peterson, D. E., Schubert, M., Keefe, D., McGuire, D., Epstein, J., Elting, L. S., Fox, P. C., Cooksley, C., Sonis, S. T., et al. (2004) · Cancer · doi:10.1002/cncr.20163 · Cited by 820
Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer
Eisbruch, A., Kim, H. M., Terrell, J. E., Marsh, L. H., Dawson, L. A., & Ship, J. A. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01512-7 · Cited by 770
Metadata
- Authors
- Brizel, D. M., Wasserman, T. H., Henke, M., Strnad, V., Rudat, V., Monnier, A., Eschwege, F., Zhang, J., Russell, L., Oster, W., & Sauer, R.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-10-19
- Volume
- 18
- Issue
- 19
- Pages
- 3339-3345
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2157885764
- Cited by
- 828
- References
- 25
- FWCI
- 40.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.